D-Lactic Acid → HCID 67494492, compound
Reaction equation
[Br:1][C:2]1[C:3]([O:24][CH:25]2[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]2)=[N:4][C:5]2[N:6]([N:9]=[CH:10][C:11]=2[C:12]2[CH:13]=[N:14][C:15]([C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)=[CH:16][CH:17]=2)[C:7]=1[NH2:8].[C:31](O)(=[O:35])[C@@H:32]([CH3:34])[OH:33].C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C>CN(C=O)C.C(Cl)CCl>[NH2:8][C:7]1[N:6]2[N:9]=[CH:10][C:11]([C:12]3[CH:13]=[N:14][C:15]([C:18]4[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=4)=[CH:16][CH:17]=3)=[C:5]2[N:4]=[C:3]([O:24][CH:25]2[CH2:30][CH2:29][N:28]([C:31](=[O:35])[C@H:32]([OH:33])[CH3:34])[CH2:27][CH2:26]2)[C:2]=1[Br:1]Participants
7
Procedure
A mixture of the crude 6-bromo-3-(6-phenylpyridin-3-yl)-5-(piperidin-4-yloxy)pyrazolo[1,5-a]pyrimidin-7-amine, D-(−)-lactic acid (18.5 mg, 0.20 mmoL), EDC (78.7 mg, 0.41 mmoL), HOBt (27.7 mg, 0.20 mmoL) and DIEA (238 uL, 1.37 mmoL) in DMF (4 mL) was stirred at room temperature for 2 hr. Purification with prep-LC provided (R)-1-(4-(7-amino-6-bromo-3-(6-phenylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yloxy)piperidin-1-yl)-2-hydroxypropan-1-one, LCMS tR=4.39 Min (10 min run, UV254nm). Mass calculated for, M+ 513.0, observed LC/MS m/z 514.43 (M+H).
Workup
- customPurification
Sources & evidence
- ORD record
- ord-4f6e3daeaaaa438e9546715feea33f73
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08591943B2
Reaction notes
Loading…